CeO2-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals

Nanomaterials (Basel). 2022 Dec 18;12(24):4484. doi: 10.3390/nano12244484.

Abstract

This study is one of the first attempts to assess CeO2 nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their complexes with 207Bi show a high stability in medically relevant media, thus encouraging the further study of these conjugates in vivo as potential combined radiopharmaceuticals.

Keywords: bismuth; nanoceria; radiolabeled nanoparticles; radiopharmaceuticals; surface functionalization.